Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
10.1152/japplphysiol.00816.2012 86 WangH.YuR.WangM.WangS.OuyangX.YanZ.et al (2023b)
PMID 12818476
Advances in metabolic medicine have introduced GLP-1 receptor agonists a doctor-supervised therapy designed to address the biological drivers of weight gain
These findings highlight the significant potential of GLP-1 medications for protecting renal function and improving outcomes for individuals with Type 2 diabetes and CKD
Apoptosis induction by S-allylcysteine, a garlic constituent, during 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis
They function specifically by inhibiting the Vitamin K Epoxide Reductase (VKOR) enzyme, effectively inducing a localized Vitamin K deficiency to slow down the liver's production of clotting factors
